These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Effect of submaximal physical exertion on serum lipid levels and the blood coagulation and fibrinolysis systems in patients with arteriosclerosis]. Markiewicz K, Cholewa M, Jazdzewski B, Gawor Z. Pol Tyg Lek; ; 39(25-26):857-61. PubMed ID: 6494044 [No Abstract] [Full Text] [Related]
9. [Blood coagulation disorders and their correction in periodontal disease]. Ivanov VS, Belikov PP. Stomatologiia (Mosk); 1985; 64(6):44-7. PubMed ID: 3866401 [No Abstract] [Full Text] [Related]
10. [Clinical research on the aged concerning the anti-sclerotic effect of a new heparinoid extract: glycuronoglucosaminoglycan sulfate (3GS)]. Turpini R, Caliandro L, Cocchi A, Volpi F, Brusaioli G, Grignani G, Antognetti R. Clin Ter; 1975 May 15; 73(3):213-36. PubMed ID: 123842 [No Abstract] [Full Text] [Related]
11. [Effect of anabolic steroid preparations on blood coagulation processes]. Karacharov AT. Klin Med (Mosk); 1971 Oct 15; 49(10):131-4. PubMed ID: 5133136 [No Abstract] [Full Text] [Related]
12. [Blood coagulation and lipid metabolism in patients with coronary arteriosclerosis]. Batrak AA. Vrach Delo; 1976 Jun 15; (6):17-9. PubMed ID: 969450 [No Abstract] [Full Text] [Related]
14. [Effect of arachidene, a preparation of unsaturated fatty acids, on the blood coagulation and anticoagulation systems in patients with coronary arteriosclerosis]. Ezhova IS. Sov Med; 1971 Jul 15; 34(7):103-7. PubMed ID: 5160310 [No Abstract] [Full Text] [Related]
18. [Blood coagulation characteristics and fibrinolytic activity in patients with coronary arteriosclerosis during a course of treatment with vetrazine]. Agapova EN, Krutovskaia OV, Mikhaĭlovskaia IG. Kardiologiia; 1968 Dec 15; 8(12):130-2. PubMed ID: 5736735 [No Abstract] [Full Text] [Related]